ClinVar Miner

Submissions for variant NM_000245.4(MET):c.1848_1849delinsTT (p.Glu616_Ser617delinsAspCys)

dbSNP: rs1794145066
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001058033 SCV001222569 uncertain significance Renal cell carcinoma 2024-01-27 criteria provided, single submitter clinical testing This variant, c.1848_1849delinsTT, is a complex sequence change that results in the deletion of 2 and insertion of 2 amino acid(s) in the MET protein (p.Glu616_Ser617delinsAspCys). Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This variant has not been reported in the literature in individuals affected with MET-related conditions. ClinVar contains an entry for this variant (Variation ID: 853254). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002409470 SCV002715846 uncertain significance Hereditary cancer-predisposing syndrome 2024-07-29 criteria provided, single submitter clinical testing The c.1848_1849delGAinsTT variant (also known as p.E616_S617delinsDC), located in coding exon 5 of the MET gene, results from an in-frame deletion of GA and insertion of TT at nucleotide positions 1848 to 1849. This results in the substitution of glutamic acid and serine residues for aspartic acid and cysteine residues at codons 616 and 617. This amino acid region is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear.
GeneDx RCV004768832 SCV005376903 uncertain significance not provided 2023-10-19 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.